ZA836031B - Constant release rate solid dosage theophylline formulation - Google Patents

Constant release rate solid dosage theophylline formulation

Info

Publication number
ZA836031B
ZA836031B ZA836031A ZA836031A ZA836031B ZA 836031 B ZA836031 B ZA 836031B ZA 836031 A ZA836031 A ZA 836031A ZA 836031 A ZA836031 A ZA 836031A ZA 836031 B ZA836031 B ZA 836031B
Authority
ZA
South Africa
Prior art keywords
release rate
solid dosage
constant release
rate solid
theophylline formulation
Prior art date
Application number
ZA836031A
Other languages
English (en)
Inventor
James Michael Dunn
Ronald Thomas Haas
Original Assignee
Verex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verex Lab filed Critical Verex Lab
Priority to ZA836031A priority Critical patent/ZA836031B/xx
Priority to AU18106/83A priority patent/AU1810683A/en
Priority to EP83108714A priority patent/EP0134290A1/en
Priority to JP58193573A priority patent/JPS6087217A/ja
Publication of ZA836031B publication Critical patent/ZA836031B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA836031A 1983-08-16 1983-08-16 Constant release rate solid dosage theophylline formulation ZA836031B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ZA836031A ZA836031B (en) 1983-08-16 1983-08-16 Constant release rate solid dosage theophylline formulation
AU18106/83A AU1810683A (en) 1983-08-16 1983-08-18 Constant release theophylline tablets
EP83108714A EP0134290A1 (en) 1983-08-16 1983-09-05 Constant release rate solid dosage theophyllineformulation
JP58193573A JPS6087217A (ja) 1983-08-16 1983-10-18 一定放出速度の固体調剤テオフイリン配合物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ZA836031A ZA836031B (en) 1983-08-16 1983-08-16 Constant release rate solid dosage theophylline formulation
AU18106/83A AU1810683A (en) 1983-08-16 1983-08-18 Constant release theophylline tablets
EP83108714A EP0134290A1 (en) 1983-08-16 1983-09-05 Constant release rate solid dosage theophyllineformulation
JP58193573A JPS6087217A (ja) 1983-08-16 1983-10-18 一定放出速度の固体調剤テオフイリン配合物

Publications (1)

Publication Number Publication Date
ZA836031B true ZA836031B (en) 1985-02-27

Family

ID=32854333

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA836031A ZA836031B (en) 1983-08-16 1983-08-16 Constant release rate solid dosage theophylline formulation

Country Status (4)

Country Link
EP (1) EP0134290A1 (xx)
JP (1) JPS6087217A (xx)
AU (1) AU1810683A (xx)
ZA (1) ZA836031B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570603B1 (fr) * 1983-04-09 1987-07-17 Nikken Chemicals Co Ltd Pastille pharmaceutique de theophylline a liberation prolongee et son procede de preparation
IL78017A (en) * 1986-03-03 1989-06-30 Yissum Res Dev Co Sustained release tablets of theophylline
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
EP1027885B1 (en) * 1999-02-09 2008-07-09 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
EP1118321A1 (fr) * 2000-01-14 2001-07-25 Ucb, S.A. Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
JP4948428B2 (ja) * 2008-01-11 2012-06-06 中国電力株式会社 銘板及び電力設備

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
IN151913B (xx) * 1980-01-11 1983-09-03 Boots Co Ltd
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication

Also Published As

Publication number Publication date
AU1810683A (en) 1985-02-21
EP0134290A1 (en) 1985-03-20
JPS6087217A (ja) 1985-05-16

Similar Documents

Publication Publication Date Title
PH18441A (en) Solid unit dosage forms
ZA828797B (en) Pharmaceutical formulation
ZA848375B (en) Medicament formulation
AU1873783A (en) Constant release formulation
GB2122490B (en) Controlled release formulation
DE3264782D1 (en) Medicinal formulation
NZ214534A (en) Sustained release formulation containing theophylline
IL74049A0 (en) Controlled release liquid dosage pharmaceutical formulations
KE3814A (en) Pharmaceutical formulations
GB2117638B (en) Pour-on formulation
ZA836031B (en) Constant release rate solid dosage theophylline formulation
ZW4583A1 (en) Pyrimidone derivatives
GB8405085D0 (en) Controlled release formulation
DE3466477D1 (en) Pharmaceutical formulations
GB8422453D0 (en) Pharmaceutical formulation
ZA859645B (en) Theophylline sustained release formulation
GB8316135D0 (en) Formulation
EG17797A (en) Controlled release formulation
GB8326645D0 (en) Pharmaceutical formulation
GB8301368D0 (en) Pharmaceutical formulation
GB8329594D0 (en) Pharmaceutical formulation
GB8308097D0 (en) Pharmaceutical formulation
GB8304454D0 (en) Pharmaceutical formulation
IE840461L (en) Controlled release formulation comprising a¹triazolobenzothiazole
IE873368L (en) Azumolene dosage form